Clinical Trial Update: Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing different ribavirin dosages and treatment durations in combination with pegylated interferon for patients with genotype 2 and 3 chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Hepatitis

Drugs mentioned

• Peginterferon (Pegylated interferon)
• Ribavirin (ribavirin)

Snippet

Sponsor: Casa Sollievo della Sofferenza IRCCS | Conditions: Chronic Hepatitis | Phase 3 | Status: COMPLETED